Skip To Content
Get Our Newsletter
JEWISH. INDEPENDENT. NONPROFIT.

Support the Forward

Funded by readers like you DonateSubscribe
Fast Forward

Auschwitz survivor among the first vaccinated in hometown of Pfizer’s CEO

Zana Sadikario-Saatsoglou, a Thessalonikan Jew and Holocaust survivor, became one of the first people in Greece to receive Pfizer’s coronavirus vaccine on Tuesday.

98-year-old Sadikario-Saatsoglou received the vaccine at Thessaloniki’s Saul Modiano Old Age Home, which serves its Jewish community. Greece received nearly 10,000 doses of the vaccine in late December and began rolling them out shortly after the new year, to the elderly and first responders.

Pfizer’s CEO, Albert Bourla, is also from Thessaloniki. His parents, like Sadikario-Saatsoglou, survived Auschwitz.

Before the war, Bourla’s ancestors were part of Thessaloniki’s large Jewish merchant class and traded jewelry, diamonds and other gems across the Balkans, according to the Central Board of Jewish Communities in Greece.

Thessaloniki was once one of the most Jewish cities in the world: nearly half its population of 118,000 was Jewish around the turn of the 20th century, according to Ottoman censuses. Jews had lived in the city as far back as biblical times. That came to an end in the years of Zana’s youth: in 1943, the city’s Jewish population was deported to Auschwitz.

She was among the few who returned.

During the war, 45,000 Jews from Thessaloniki were sent to Auschwitz, according the United States Holocaust Memorial Museum; 5,000 are believed to have survived. Overall, 81% of Greek Jewry were murdered by the Nazis, a death rate rivaled only by major European Jewish centers like Poland and Lithuania.

Engage

  • SHARE YOUR FEEDBACK

  • UPCOMING EVENT

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free under an Attribution-Non Commercial-No Derivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit Foward and retain our pixel. See our full guidelines for more information.

To republish, copy the HTML, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline, and credit to Foward. Have questions? Please email us at help@forward.com.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.